Versant Ventures VI GP, L.P.'s Net Worth

$0

Estimate Recalculated Nov 11, 2024 08:47AM EST

Who is Versant Ventures VI GP, L.P.?

Versant Ventures VI GP, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Monte Rosa Therapeutics, Inc., Oyster Point Pharma, Inc., Pandion Therapeutics Holdco LLC, Passage BIO, Inc., Contineum Therapeutics, Inc., LENZ Therapeutics, Inc., Repare Therapeutics Inc., Century Therapeutics, Inc., Tempest Therapeutics, Inc., and Akero Therapeutics, Inc..

SEC CIK

Versant Ventures VI GP, L.P.'s CIK is 0001777654

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

LENZ Therapeutics, Inc. (GRPH) No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+245.21%
598.2K
—
—
842.16K
Mar 21
Form 4
+594.22%
14.05M
$17.00
—
16.42M
Jun 29
Form 3
—
0
—
—
0
No matching records found

Repare Therapeutics Inc. (RPTX) Snapshot price: $2.8

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-22.54%
-1.45M
$12.25
-$9,188,775.00
4.98M
Jun 3 - Jun 6
Form 4
-39.68%
-152.07K
—
—
231.21K
Scheduled
Aug 5
Form 4
-16.37%
-75.00K
—
—
383.28K
Jun 1
Form 4
-9.99%
-240.75K
—
—
2.17M
Scheduled
May 5
Form 4
-10.29%
-350.00K
—
—
3.05M
Scheduled
Feb 16
Form 4
-9.36%
-600.00K
—
—
5.81M
Scheduled
Jan 29
Form 4
-7.23%
-500.00K
—
—
6.41M
Scheduled
Jan 14
Form 4
-10.12%
-325.00K
—
—
2.88M
Scheduled
Dec 15
Form 4
+64.65%
6.5M
$20.00
$5,000,000.00
16.54M
Jun 23
Form 3
—
0
—
—
0
No matching records found

Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $5.69

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-14.24%
-1.54M
$9.41
-$1,491,041.15
9.3M
Oct 28 - Oct 29
Form 4
-8.34%
-567.21K
$6.00
-$3,404,791.10
6.23M
Sep 11 - Sep 13
Form 4
+3,041.10%
8.61M
$19.00
—
8.9M
Jun 28
Form 3
—
0
—
—
0
No matching records found

Century Therapeutics, Inc. (IPSC) Snapshot price: $1.44

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-7.40%
-914.80K
$13.03
-$7,166,610.00
11.45M
Scheduled
Aug 9
Form 4
-1.43%
-179.00K
—
—
12.37M
Jan 31
Form 4
-2.87%
-371.00K
—
—
12.55M
Scheduled
Dec 23
Form 4
+357.29%
10.65M
$20.00
—
13.63M
Jun 22
Form 3
—
0
—
—
0
No matching records found

Oyster Point Pharma, Inc. No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.66M
—
—
0
Jan 3
Form 4
-32.57%
-201.47K
—
—
417.07K
Scheduled
Jan 5
Form 4
-24.57%
-201.47K
—
—
618.55K
Scheduled
Dec 21
Form 4
-22.59%
-550.00K
$14.86
-$8,160,736.41
1.88M
Scheduled
Oct 18
Form 4
-19.05%
-322.36K
—
—
1.37M
May 12
Form 4
-16.00%
-322.36K
—
—
1.69M
Mar 26
Form 4
-12.69%
-325.00K
—
—
2.24M
Scheduled
Feb 17
Form 4
+1,630.55%
5.26M
$16.00
—
5.58M
Nov 4
Form 3
—
0
—
—
0
No matching records found